Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: NPT, PDT, LIC

Vivera Pharmaceuticals Collaborates With DoctorsOne Healthcare Systems and Manny Pacquiao Foundation for Joint Vaccine Initiative in Underserved SoCal Communities


NEWPORT BEACH, Calif., Sept. 21, 2021 /PRNewswire/ -- Vivera Pharmaceuticals, Inc., in partnership with DoctorsOne Healthcare Systems (Doc1 Health) and the Manny Pacquiao Foundation, announced the launch of a joint vaccination initiative in Southern California. 

Partnerships like ours have proved vital in protecting the health and safety of Americans across the nation

By bringing together each teams' respective expertise, the initiative strives to increase awareness for the low vaccination rates among underserved communities of Los Angeles County.

With a less than 20 percent average vaccination rate among communities of color nationwide, the partnership aims to shine a light on the importance of vaccinations, especially as the Delta variant of COVID-19 increases in prevalence.  

"From day one of the COVID-19 pandemic, partnerships like ours have proved vital in protecting the health and safety of Americans across the nation," explained Chairman and CEO of Vivera, Paul Edalat. "Now more than ever, it's important that we do our part to ensure our most vulnerable here in Los Angeles have the life-saving vaccine education and access they need."

The partnership between Vivera and Doc1 Health will lead to various awareness campaigns and vaccination events in several Southern California communities. Vivera and Doc1 Health will continue to work with community partners to ensure immediate testing access for the most vulnerable population of Los Angeles through the coordination of large-scale testing events. Through its partnership with Areum Bio LLC and Access Bio, Inc., Vivera is distributing Access Bio's FDA-authorized CareStarttm COVID-19 Antigen Test and providing these tests to be used during the events.

"The COVID-19 pandemic has been disproportionately devastating for underserved populations," explained Lea Ramirez, Founder and CEO of Doc1 Health. "By expanding local vaccine access, we can do our best to protect our communities from the worst effects of the Delta variant, which has proved particularly deadly since its inception."

The Manny Pacquiao Foundation, founded by Manny Pacquiao, an eight-division World Boxing Champion, and current Philippine Senator, is spearheading community outreach efforts for the campaign.

"The Pacquiao Foundation is dedicated to fighting for those in need around the world and has reached over one million people in need of help since its establishment in 2019," states Jon Sisson, Executive Director of the Manny Pacquiao Foundation. "This joint venture with Vivera and Doc1 perfectly encapsulates our mission to bring hope wherever it is needed."

About Vivera Pharmaceuticals 
Vivera Pharmaceuticals is an innovative, science-driven pharmaceutical company located in Southern California. The Company has global exclusivity to license the patented and patent-pending TABMELT® sublingual drug delivery system for pharmaceutical use and owns its own patents on ZICOH®, a controlled medication dispensing device. In addition to its pharmaceutical, neurosciences, medical device, and medical technology divisions, the Company provides testing solutions through its advanced diagnostics division. Vivera Pharmaceuticals is vertically integrated with patented technology, manufacturing capabilities, and distribution for its products.

For more information, please visit viverapharmaceuticals.com or connect with us on LinkedIn, Facebook, Twitter, or Instagram.

About DoctorsOne Healthcare Systems
Developed by doctors, DoctorsOne Healthcare Systems (Doc1 Health) is first and foremost patient-centric. Doc1 Health was born out of the need for consistent, quality patient care throughout the healthcare delivery system. The healthcare professionals at Doc1 Health are passionate about providing the highest levels of patient care laterally throughout the healthcare spectrum, with the intent to standardize quality of care in all aspects of the patient experience. For excellence from training to practice, the Doc1 Academy, Hospital Division, Medical Professional Network, and Post-Acute Care Division were established to synchronize quality in healthcare from all levels of the system. As a comprehensive Healthcare System for patients, providers, and partners, Doc1 Health utilizes over 100 years of combined experience integrated with clear data and outcome driven metrics.

For more information, please visit our website at doc1health.com and connect with us on LinkedInFacebook, or Instagram

About the Manny Pacquiao Foundation
The Manny Pacquiao Foundation (MPF) is a California 501 (c)(3) nonprofit. It is the charitable organization of the eight-division World Boxing Champion and current Philippine Senator, Emmanuel (Manny) Pacquiao. Established in 2019, the MPF is committed to fighting for those less fortunate and spreading hope around the world. It represents the embodiment of the people's champion, Manny Pacquiao, who has devoted himself to public service and donated more than one-third of his career earnings to charity. It is his goal to be an instrument of hope and change around the world. The MPF has already reached over one million people in need of help and continues to inspire others by creating a sustainable impact that transcends the world of sport.

For more information, please visit pacquiaofoundation.org.

Contact: Megan Kay
[email protected]
818-850-8694

SOURCE Vivera Pharmaceuticals, Inc.


These press releases may also interest you

at 08:35
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor...

at 08:35
Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice...

at 08:33
1MD Nutrition, a leading developer of physician-formulated, condition-specific nutritional supplements with key ingredients in therapeutically significant dosages from substantiated, human clinical trials, is now a "Proud Partner" of the...

at 08:25
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:19
Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of...



News published on and distributed by: